Kairos Pharma KAPA
NYSE KAPA
$0.60 +0.02 (+2.79%)
As of: Oct 21, 2026 · 3:26 PM EDT

Kairos Pharma (KAPA) Non-Current Debt (2024)

Updated

Analysis

Kairos Pharma (KAPA) Non-Current Debt (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,137.85 Bn 1,106.43 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 618.85 Bn 537.37 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.03 Bn 476.14 Bn 12.70 Bn 62.48 Bn
4 Merck 368.52 Bn 322.90 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.19 Bn 262.18 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.14 Bn 192.53 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.35 Bn 165.54 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn 60.50 Bn
10 Kairos Pharma 10.76 Mn -1.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 40,000.00
API Access

Kairos Pharma Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=KAPA&period=max&api_key=YOUR_API_KEY